Shared Savings Program Public Reporting Template – A5305
ACO Name and Location
Centrus Health of Kansas LLC
2330 Shawnee Mission Pkwy
Ste 300
Westwood, KS 66205
ACO Primary Contact
Jamie Stevens
913-708-1169
Jstevens@centrushealth.com
Organizational Information
ACO Participants:
| ACO Participants | ACO Participant in Joint Venture |
|---|---|
| AMMAR KHALIFA, MD, LLC | NO |
| KANSAS CITY PHYSICIAN PARTNERS INC | NO |
| LIBERTY HOSPITAL URGENT CARE, LLC | NO |
| NEW LIBERTY HOSPITAL CORPORATION | NO |
| UNIVERSITY OF KANSAS HOSPITAL AUTHORITY | NO |
ACO Governing Body:
| Member First Name | Member Last Name | Member Title/Position | Member's Voting Power (Expressed as a percentage or number) | Membership Type | ACO Participant Legal Business Name and D/B/A, if applicable |
|---|---|---|---|---|---|
| Eyad | Al-hihi, MD | Member | 25% | ACO Participant Representative | University of Kansas Hospital Authority |
| Yvette | Guislain, MD | Member | 0% | Community Stakeholder Representative | Sunflower Medical Group |
| Loree | Cordova, MD | Member | 0% | Community Stakeholder Representative | AdventHealth Shawnee Mission |
| Branden | Comfort, MD | Member | 25% | ACO Participant Representative | University Kansas Hospital Association |
| Russell | Rein | Member | 25% | ACO Participant Representative | New Liberty Hospital Corporation |
| Rick | Green | Member | 0% | Community Stakeholder Representative | Meritas Health Corp. |
| Brooke | Varnum, MD | Member | 0% | Community Stakeholder Representative | AdventHealth Shawnee Mission |
| Crystal | LaGalle, DO | Member | 0% | Community Stakeholder Representative | Meritas Health Corp. |
| Kenna | Belshe, DO | Chair | 0 | Community Stakeholder Representative | Meritas Health Corp. |
| AJ | Delaney, MD | Vice Chair | 0% | ACO Participant Representative | Clay Platte Family Medicine Clinic |
| James | Piotnek, MD | Member | 25% | Medicare Beneficiary Representative | N/A |
| Shana | Tauai | Member | 0% | Community Stakeholder Representative | AdventHealth Shawnee Mission |
Key ACO Clinical and Administrative Leadership:
ACO Executive: Jamie Stevens
Medical Director: Branden Comfort, MD
Compliance Officer: Reyann Davis
Quality Assurance/Improvement Officer: Atonya Reshard
Associated Committees and Committee Leadership:
| Committee Name | Committee Leader Name and Position |
|---|---|
| Care Delivery & Quality Committee | Andrew Jurgensmeier, MD; Chair |
| Payment Transformation & Finance Committee | Nathan Granger, MD; Chair |
Types of ACO Participants, or Combinations of Participants, That Formed the ACO:
- ACO professionals in a group practice arrangement
- Hospital employing ACO professionals
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses:
- First Agreement Period
- Performance Year 2023, $0
Shared Savings Distribution:
- First Agreement Period
- Performance Year 2023
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 95%
- Performance Year 2023
Quality Performance Results
2023 Quality Performance Results:
Quality performance results are based on the CMS Web Interface & CAHPS for MIPS Survey collection type.
| Measure # | Measure Name | Collection Type | Reported Performance Rate | Current Year Mean Performance Rate (SSP ACOs) |
|---|---|---|---|---|
| Measure #: 001 | Diabetes Mellitus: Hemoglobin A1c Poor Control | CMS Web Interface | 17.21 | 9.84 |
| Measure #: 110 | Preventive Care and Screening: Influenza Immunization | CMS Web Interface | 67.59 | 70.76 |
| Measure #: 112 | Breast Cancer Screening | CMS Web Interface | 75.19 | 80.36 |
| Measure #: 113 | Colorectal Cancer Screening | CMS Web Interface | 70.28 | 77.14 |
| Measure #: 134 | Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan | CMS Web Interface | 83.71 | 80.97 |
| Measure #: 226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 38.10 | 79.29 |
| Measure #: 236 | Hypertension (HTN): Controlling High Blood Pressure | CMS Web Interface | 61.11 | 77.80 |
| Measure #: 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 92.70 | 89.42 |
| Measure #: 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 85.66 | 87.05 |
| Measure #: 479 | 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | CMS Web Interface | 0.1541 | 0.1553 |
| Measure #: 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | CMS Web Interface | 38.33 | 35.39 |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 83.11 | 83.68 |
| CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 94.48 | 93.69 |
| CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 93.22 | 92.14 |
| CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 76.14 | 75.97 |
| CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 68.33 | 63.93 |
| CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 58.41 | 61.60 |
| CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 68.03 | 74.12 |
| CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 89.53 | 85.77 |
| CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 95.93 | 92.31 |
| CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 37.76 | 26.69 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov
Fraud and Abuse Waivers
ACO Pre-Participation Waiver:
The following information describes each arrangement for which our ACO seeks protection under the ACO Pre-Participation Waiver, including any material amendment or modification to a disclosed arrangement.
For each arrangement, provide the following information:
- N/A
ACO Participation Waiver:
The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.
For each arrangement, provide the following information:
- Parties to the arrangement: All Participant TINs
- Date of arrangement: January 1, 2018
- Items, services, goods, or facility provided: Population Health Management Services
- Date and nature of any amendments to the arrangement, if applicable: N/A